Vilacto Bio (Vilacto Bio) Receivables Turnover : 0.00 (As of Jun. 2019)

View and export this data going back to 2013. Start your Free Trial

What is Vilacto Bio Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Vilacto Bio's Revenue for the three months ended in Jun. 2019 was $0.01 Mil. Vilacto Bio's average Accounts Receivable for the three months ended in Jun. 2019 was $0.00 Mil.

Vilacto Bio Receivables Turnover Historical Data

The historical data trend for Vilacto Bio's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilacto Bio Receivables Turnover Chart

Vilacto Bio Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Receivables Turnover

Get a 7-Day Free Trial

Vilacto Bio Quarterly Data
	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19
Receivables Turnover	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Vilacto Bio's Receivables Turnover

For the Biotechnology subindustry, Vilacto Bio's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilacto Bio's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vilacto Bio's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Vilacto Bio's Receivables Turnover falls into.

Vilacto Bio Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Vilacto Bio's Receivables Turnover for the fiscal year that ended in Mar. 2019 is calculated as

	Receivables Turnover (A: Mar. 2019 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2019 )	/ (	(Accounts Receivable (A: Mar. 2018 )	+	Accounts Receivable (A: Mar. 2019 ))	/	count )
=	0.005	/ (	(0	+	0)	/	1 )
=	0.005	/	0
=	N/A

Vilacto Bio's Receivables Turnover for the quarter that ended in Jun. 2019 is calculated as

	Receivables Turnover (Q: Jun. 2019 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Jun. 2019 )	/ (	(Accounts Receivable (Q: Mar. 2019 )	+	Accounts Receivable (Q: Jun. 2019 ))	/	count )
=	0.005	/ (	(0	+	0)	/	1 )
=	0.005	/	0
=	N/A

Vilacto Bio (GREY:VIBI) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Vilacto Bio Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Vilacto Bio's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilacto Bio (Vilacto Bio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vilacto Bio Inc (GREY:VIBI) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fabriksvej 48, Suite 2607, The Seagram Building, Naestved, DNK, 4700

Website

https://www.vilacto.com

Vilacto Bio Inc is a biotech company. It operates a fully patented Lactoactive molecule for treating conditions such as inflammatory diseases, diabetics, psoriasis, and skin issues in different levels. The company is also intended to develop Lactoactive molecule for increasing the quality of its retail and medical skin cream product as well as developing products for medical applications. Its product portfolio includes lotions, skin care creams and gels, lip balms, foot creams and oils, and others.